摘要
目的观察脑蛋白水解物治疗糖尿病周围神经病变的临床疗效。方法 10 5例糖尿病神经病变患者随机分为治疗组(3 4例 )、标准对照组 (3 8例 )和空白对照组 (3 3例 ) ,分别给予静脉注射脑蛋白水解物、肌肉注射弥可保联合静脉注射爱维治和口服B族维生素治疗 ,观察各组患者的疗效。结果静脉注射脑蛋白水解物能够改善临床症状 ,提高神经传导速度 ,与肌肉注射弥可保联合静脉注射爱维治治疗效果基本相同。结论脑蛋白水解物能够用于糖尿病神经病变治疗。
ObjectiveTo investigate the effect of cerebroprotein hydrolysate on diabetic peripheral neuropathy.Methods105 diabetic patients were randomly divided into the treatment group (34 cases, treated with intravenous injection of cerebroprotein hydrolysate), standard control group (38 cases, treated with intramuscular injection of Metrycobal combined with intravenous injection of Actovegin) and blank control group (33 cases, treated with oral vitamin B1, B6, B12). Curative effects of three groups were evaluated.ResultsIt was shown that intravenous injection of cerebropotein hydrolysate could improve patients' symptoms, raised speed of nerve conduction and its curative effect was as same as intramuscular injection of Metrycobal combined with intravenous injection of Actovegin.ConclusionIntravenous injection of cerebropotein hydrolysate has a curation effect on diabetic peripheral neuropathy.
出处
《中国康复理论与实践》
CSCD
2004年第4期229-230,共2页
Chinese Journal of Rehabilitation Theory and Practice
关键词
糖尿病
神经病变
脑蛋白水解物
diabetes
neuropathy
cerebropotein hydrolysate
